Stock Fundamentals

Company Information

Company Name
Cellectar Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US15117F8077
CIK: 0001279704
CUSIP: 67000M100
Currency: USD
Full Time Employees: 11
Phone: 608 441 8120
Fiscal Year End: December
IPO Date: Nov 10, 2005
Description:

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR125, an iodine-125 Auger-emitting radioconjugate program; and CLR 225, an actinium-225 based program. The company has collaborative with Orano Med to develop alpha emitter lead-212 conjugated to phospholipid ether series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Address:

100 Campus Drive, Florham Park, NJ, United States, 07932

Directors & Officers

Name Title Year Born
Mr. James V. Caruso President, CEO & Director 1959
Mr. Jarrod Longcor Chief Operating Officer 1973

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 12, 2025 John Neis N/A Sale 198.00 $3.70 $732.60
Jul 02, 2025 Chad J Kolean N/A Purchase 5.00K $4.99 $24.95K
Jul 02, 2025 James V Caruso N/A Purchase 10.00K $4.99 $49.90K
Jul 02, 2025 Jarrod Longcor N/A Purchase 10.00K $4.99 $49.90K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Bleichroeder LP 100.00K Mar 31, 2026 2.36% $0.04 0.00%
Vanguard Group Inc 89.12K Dec 31, 2025 2.10% $0.00 36.75%
Geode Capital Management, LLC 52.78K Mar 31, 2026 1.24% $0.00 84.31%
Sequoia Financial Advisors LLC 18.85K Mar 31, 2026 0.44% $0.00 -25.64%
Warberg Asset Management LLC 13.90K Mar 31, 2026 0.33% $0.01 0.00%
Riverview Capital Advisers LLC 10.38K Mar 31, 2026 0.24% $0.02 0.00%
UBS Group AG 9.65K Mar 31, 2026 0.23% $0.00 271.32%
BlackRock Inc 4.75K Mar 31, 2026 0.11% $0.00 0.00%
Tower Research Capital LLC 793.00 Mar 31, 2026 0.02% $0.00 -56.74%
Morgan Stanley - Brokerage Accounts 510.00 Mar 31, 2026 0.01% $0.00 0.00%
TD Waterhouse Canada Inc 63.00 Mar 31, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 11.00 Mar 31, 2026 0.00% $0.00 0.00%
FMR Inc 10.00 Mar 31, 2026 0.00% $0.00 0.00%
U.S. Bancorp 3.00 Mar 31, 2026 0.00% $0.00 0.00%
JONES FINANCIAL COMPANIES LLLP 3.00 Mar 31, 2026 0.00% $0.00 0.00%
Danske Bank A/S. 2.00 Mar 31, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 1.00 Mar 31, 2026 0.00% $0.00 -85.71%
Susquehanna International Group, LLP 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
ACT Capital Management, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Citadel Advisors Llc 0.00 Dec 31, 2025 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 7.99M
Shares Float: 7.82M
% Insiders: 207.20%
% Institutions: 662.90%
Short % Float: 9.77%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 50.77K 1.20% ▲ 0.00% Apr 30, 2026
2 Fidelity Extended Market Index 35.71K 0.84% ▲ 68.17% Mar 31, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 31.11K 0.73% ▲ 0.00% Apr 30, 2026
4 Abante Quant Value FI 18.07K 0.43% ▲ 0.00% Mar 31, 2026
5 Northern Trust Extended Eq Market Idx 6.94K 0.16% ▲ 324.66% Mar 31, 2026
6 NT Ext Equity Mkt Index Fund - Lending 6.94K 0.16% ▲ 0.00% Mar 31, 2026
7 DFA US Small Cap I 6.14K 0.14% ▲ 0.00% Mar 31, 2026
8 Spartan Extended Market Index Pool F 6.11K 0.14% ▲ 170.44% Mar 31, 2026
9 Fidelity Series Total Market Index 5.64K 0.13% ▲ 20.95% Mar 31, 2026
10 Spartan Total Market Index Pool G 3.04K 0.07% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $17.52M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $20.78M
EBITDA: $-22.16M
PEG Ratio: $0.00
Book Value: $0.66
Earnings/Share: $-5.38
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -102.96%
ROE (TTM): -290.42%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.96x 0.01x 0.34x N/A 0.00x
2024-12-31 2.58x 0.01x 0.44x N/A 0.00x
2023-12-31 0.41x 0.00x 2.14x N/A 0.00x
2022-12-31 1.78x 0.01x 0.56x -95.74x 0.00x
2021-12-31 9.16x 0.00x 0.11x -10,565.36x -0.01x
2020-12-31 16.26x 0.00x 0.07x -1,403.17x -0.01x
2019-12-31 4.11x 0.01x 0.26x -331.96x -0.01x
2018-12-31 8.60x 0.00x 0.12x -449.04x 0.00x
2017-12-31 4.95x 0.00x 0.16x -819.09x 0.00x
2016-12-31 7.47x 0.01x 0.12x -1,196.63x -0.01x
2015-12-31 0.73x 0.20x 0.78x -10,413.63x -0.03x
2014-12-31 1.56x 0.04x 0.20x -22.16x -0.05x
2013-12-31 0.61x 0.27x 0.75x -1,326.68x -0.04x
2012-12-31 7.00x 0.04x 0.11x -937.85x -0.05x
2011-12-31 11.55x 0.05x 0.10x -16.37x -0.07x
2010-12-31 2.69x 3.19x 0.51x -2,251.42x -0.30x
2009-12-31 0.52x -0.12x 4.01x -10,097.89x -0.31x
2008-12-31 0.21x 0.00x 4.81x -127.03x 0.00x
2007-12-31 1.57x 0.00x 1.53x N/A 0.00x
2006-12-31 9.05x 0.00x 0.11x N/A 0.00x
2005-12-31 22.11x 0.00x 0.04x N/A 0.00x
2004-12-31 0.02x -0.46x 41.06x -3.00x -3.34x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CLRB.US!